Please assess the completion status of the following clinical trial:

Trial Title: Strategic Timing of Antiretroviral Treatment

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
INCLUSION CRITERIA:~* Signed informed consent~* HIV infection documented by a plasma HIV RNA viral load, rapid HIV test or any licensed\* ELISA test; and confirmed by another test using a different method including but not limited to a rapid HIV test, Western Blot, HIV culture, HIV antigen, or HIV pro-viral DNA at any time prior to study entry.~* Age greater than or equal to 18 years~* Karnofsky performance score greater than or equal to 80 (an indication that the participant can perform normal activities)~* Perceived life expectancy of at least 6 months~* For women of child-bearing potential, willingness to use contraceptives as described in the product information of the ART drugs they are prescribed~* Two CD4+ cell counts greater than 500 cells/mm(3) at least 2 weeks apart within 60 days before randomization~  * The term licensed refers to an FDA-approved kit or, for sites located in countries other than the United States, a kit that has been certified or licensed by an oversight body within that country. Confirmation of the initial test result must use a test method that is different than the one used for the initial assessment.~EXCLUSION CRITERIA:~* Any previous use of ART or interleukin-2 (IL-2)~* Diagnosis of any clinical AIDS event before randomization (including esophageal candidiasis and chronic Herpes simplex infection)~* Presence of HIV progression such as oral thrush, unexplained weight loss, or unexplained fever~* Cardiovascular event (myocardial infarction, angioplasty, coronary-artery bypass grafting, stroke) within 6 months before randomization~* Non-AIDS-defining cancer, excluding basal and squamous cell skin cancer, within 6 months before randomization~* Dialysis within 6 months before randomization~* Diagnosis of decompensated liver disease before randomization~* Current imprisonment, or compulsory detention (involuntary incarceration) for treatment of a psychiatric or physical illness~* Current pregnancy or breastfeeding (a negative serum or urine pregnancy test is required within 14 days before randomization for women of child-bearing potential)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Early ART (Type: EXPERIMENTAL): Initiate ART immediately following randomization
- Deferred ART (Type: ACTIVE_COMPARATOR): Defer ART until the CD4+ count declines to \<350 cells/cu mm or AIDS develops

Based on this trial design, predict the completion outcome and termination type (if applicable).